Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

May 16, 2008

Primary Completion Date

December 22, 2008

Study Completion Date

December 22, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK233705 12.5mcg

Once daily via dry powder inhaler

DRUG

GSK233705 25mcg

once daily via dry powder inhaler

DRUG

GSK233705 50mcg

Once daily via dry powder inhaler

DRUG

GSK233705 100mcg

Once daily via dry powder inhaler

DRUG

GSK233705 200mcg

Once daily via dry powder inhaler

DRUG

Placebo

Once daily via dry powder imhaler

Trial Locations (88)

1095

GSK Investigational Site, Budapest

1100

GSK Investigational Site, Quezon City

1109

GSK Investigational Site, Quezon City

1431

GSK Investigational Site, Sofia

2193

GSK Investigational Site, Parktown

2660

GSK Investigational Site, Balassagyarmat

2700

GSK Investigational Site, Pergamino

3233

GSK Investigational Site, Mátraháza

4000

GSK Investigational Site, San Miguel de Tucumán

4114

GSK Investigational Site, Cavite

6400

GSK Investigational Site, Dimitrovgrad

7000

GSK Investigational Site, Rousse

7505

GSK Investigational Site, Cape Town

7531

GSK Investigational Site, Bellville

7600

GSK Investigational Site, Mar del Plata

7700

GSK Investigational Site, Mowbray

10117

GSK Investigational Site, Berlin

10559

GSK Investigational Site, Berlin

10700

GSK Investigational Site, Bangkok

10717

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

14057

GSK Investigational Site, Berlin

23229

GSK Investigational Site, Richmond

23552

GSK Investigational Site, Lübeck

24210

GSK Investigational Site, Abingdon

28207

GSK Investigational Site, Charlotte

29303

GSK Investigational Site, Spartanburg

29379

GSK Investigational Site, Union

29615

GSK Investigational Site, Greenville

30159

GSK Investigational Site, Hanover

30167

GSK Investigational Site, Hanover

32405

GSK Investigational Site, Panama City

33143

GSK Investigational Site, South Miami

33511

GSK Investigational Site, Brandon

35501

GSK Investigational Site, Jasper

39112

GSK Investigational Site, Magdeburg

40002

GSK Investigational Site, Khon Kaen

42431

GSK Investigational Site, Madisonville

50200

GSK Investigational Site, Chiang Mai

63301

GSK Investigational Site, Saint Charles

63571

GSK Investigational Site, Gelnhausen

69168

GSK Investigational Site, Wiesloch

70503

GSK Investigational Site, Lafayette

70584

GSK Investigational Site, Sunset

77030

GSK Investigational Site, Houston

83814

GSK Investigational Site, Coeur d'Alene

85306

GSK Investigational Site, Glendale

90048

GSK Investigational Site, Los Angeles

90095

GSK Investigational Site, Los Angeles

90110

GSK Investigational Site, Songkhla

92506

GSK Investigational Site, Riverside

92708

GSK Investigational Site, Fountain Valley

92835

GSK Investigational Site, Fullerton

95661

GSK Investigational Site, Roseville

500112

GSK Investigational Site, Brasov

700115

GSK Investigational Site, Iași

2341131

GSK Investigational Site, Valparaíso

7500551

GSK Investigational Site, Santiago

7500691

GSK Investigational Site, Santiago

8380453

GSK Investigational Site, Santiago

92103-8415

GSK Investigational Site, San Diego

29406-7108

GSK Investigational Site, Charleston

CP1900

GSK Investigational Site, La Plata

B7600FZN

GSK Investigational Site, Mar del Plata

Unknown

GSK Investigational Site, Sofia

GSK Investigational Site, Santiago

T2N 4N1

GSK Investigational Site, Calgary

A0A 1G0

GSK Investigational Site, Bay Roberts

L5A 3V4

GSK Investigational Site, Mississauga

K1H 8L6

GSK Investigational Site, Ottawa

M5G 1N8

GSK Investigational Site, Toronto

G6W 5M6

GSK Investigational Site, Saint Romuald

J7Z 5T3

GSK Investigational Site, Sainte Jerome

G1V 4G5

GSK Investigational Site, Sainte-Foy

01307

GSK Investigational Site, Dresden

04626

GSK Investigational Site, Schmölln

H-1529

GSK Investigational Site, Budapest

7609 PP

GSK Investigational Site, Almelo

5623 EJ

GSK Investigational Site, Eindhoven

2134 TM

GSK Investigational Site, Hoofddorp

1624 NP

GSK Investigational Site, Hoorn

020125

GSK Investigational Site, Bucharest

0001

GSK Investigational Site, Mueckelneck

133--792

GSK Investigational Site, Seoul

152-703

GSK Investigational Site, Seoul

BN2 5BE

GSK Investigational Site, Brighton

SE5 9PJ

GSK Investigational Site, London

NR4 7UY

GSK Investigational Site, Norwich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00676052 - Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter